(VHT) Vanguard Health Care ETF
About this fund
Fund objectives
Vanguard Health Care ETF seeks to track the performance of a benchmark index that measures the investment return of health care stocks.
Why this fund
- Seeks to track the performance of the MSCI US Investable Market Health Care 25/50 Index.
- Multicapitalization equity in the health care sector.
- The fund employs a passively managed, full-replication strategy when possible.
- If regulatory constraints prevent full replication, the fund uses a sampling strategy to approximate the index’s key characteristics.
- The fund remains fully invested.
- Low expenses minimize net tracking error.
Fund facts
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
As at Aug 31 2026
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Portfolio data
Characteristics
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 416 | 411 | Aug 31 2026 |
| Median market capital | 162.2 B | 162.2 B | Aug 31 2026 |
| 30.9 x | 30.9 x | Aug 31 2026 | |
| 4.8 x | 4.8 x | Aug 31 2026 | |
| 20.4% | 20.4% | Aug 31 2026 | |
| 9.5% | 9.5% | Aug 31 2026 | |
| Turnover rate | 3.6% | — | Aug 31 2025 |
Market allocation
As at Aug 31 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United States of America | North America | 100.00% | 100.00% | 0.00% |
| Other | Other | 0.00% | 0.00% | 0.00% |
Top 10 holdings
As at
The 10 main holdings represent of the market value
Holdings details
As at Aug 31 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| Eli Lilly & Co | 12.79118% | Health Care | US | $2,825,885,606.35 | 2,442,995 |
| Johnson & Johnson | 8.72018% | Health Care | US | $1,926,502,495.45 | 7,246,577 |
| AbbVie Inc | 6.25843% | Health Care | US | $1,382,641,769.16 | 5,392,098 |
| Merck & Co Inc | 5.04139% | Health Care | US | $1,113,767,449.04 | 7,537,679 |
| UnitedHealth Group Inc | 4.88530% | Health Care | US | $1,079,281,746.62 | 2,771,582 |
| Amgen Inc | 3.20504% | Health Care | US | $708,071,683.44 | 1,647,138 |
| Thermo Fisher Scientific Inc | 3.16790% | Health Care | US | $699,867,920.40 | 1,134,124 |
| Abbott Laboratories | 2.65545% | Health Care | US | $586,655,109.16 | 5,315,831 |
| Gilead Sciences Inc | 2.50995% | Health Care | US | $554,508,747.54 | 3,789,181 |
| Pfizer Inc | 2.24079% | Health Care | US | $495,046,246.22 | 17,394,457 |
Prices and distribution
Prices
Historical Prices
-
Inception date
Jan 26 2004
Listing date
Jan 26 2004
| Date | NAV (USD) | Market price (USD) |
|---|---|---|
| Oct 12 2026 | $320.7000 | $320.6700 |
| Oct 09 2026 | $319.0500 | $319.0100 |
| Oct 08 2026 | $313.9500 | $313.8500 |
| Oct 07 2026 | $315.3900 | $315.3100 |
| Oct 06 2026 | $312.8600 | $312.8800 |
| Oct 05 2026 | $314.4200 | $314.5100 |
| Oct 02 2026 | $311.7800 | $311.9000 |
| Oct 01 2026 | $311.6400 | $316.0800 |
| Sep 30 2026 | $315.9500 | $316.0800 |
| Sep 29 2026 | $319.7700 | $319.7900 |
Distribution history
Distribution frequency
Quarterly
| Type | Distribution amount (per unit) | Ex-dividend date | Record date | Payment date |
|---|---|---|---|---|
| Income | $0.9685 | Sep 23 2026 | Sep 23 2026 | Sep 25 2026 |
| Income | $0.9868 | Jun 24 2026 | Jun 24 2026 | Jun 26 2026 |
| Income | $0.9940 | Mar 24 2026 | Mar 24 2026 | Mar 26 2026 |
| Income | $1.6654 | Dec 17 2025 | Dec 17 2025 | Dec 19 2025 |
| Income | $1.0765 | Sep 24 2025 | Sep 24 2025 | Sep 26 2025 |
| Income | $0.9619 | Jun 26 2025 | Jun 26 2025 | Jun 30 2025 |
| Income | $0.9396 | Mar 25 2025 | Mar 25 2025 | Mar 27 2025 |
| Income | $0.9188 | Dec 18 2024 | Dec 18 2024 | Dec 20 2024 |
| Income | $1.1666 | Sep 27 2024 | Sep 27 2024 | Oct 01 2024 |
| Income | $0.9656 | Jun 28 2024 | Jun 28 2024 | Jul 02 2024 |
Purchase information
Currencies and stock exchanges
Base currency:USD
Exchanges: New York Stock Exchange Arca
Fund codes
- Exchange ticker:VHT
- CUSIP:92204A504
- ISIN:US92204A5048
- Reuters:VHT.P
- SEDOL:2354200
Please see the fund’s fact sheet and prospectus for important information about risk’s specific to the fund. All investing is subject to risk, which may result in loss of principal. Prices of mid-and small-cap stocks often fluctuate more than those of large-company stocks. Stocks of companies based in emerging markets are subject to national and regional political and economic risks and to the risk of currency fluctuations. These risks are especially high in emerging markets. Funds that concentrate on a relatively narrow market sector face the risk of higher share-price volatility.